Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-004504

CFO and Treasurer sold 50,000 shares at an average $71.45 ($3,572,556)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krognes Steve E. CFO and Treasurer 2021-01-15 Sale −14,801 $70.10 $1,037,535 985,199 I
Krognes Steve E. CFO and Treasurer 2021-01-15 Sale −12,981 $70.96 $921,158 972,218 I
Krognes Steve E. CFO and Treasurer 2021-01-15 Sale −8,071 $71.99 $581,047 964,147 I
Krognes Steve E. CFO and Treasurer 2021-01-15 Sale −14,147 $73.01 $1,032,816 950,000 I
Open-market sales · 50,000 sh · avg $71.45 · $3,572,556
Loading xslF345X03/doc4.xml…